NeurAxis Proceeding According To Plan And The Market Is Starting To Notice

NeurAxis (NRXS) is in the early commercial stages of introducing its flagship product, the IB-Stim, a device designed to treat pediatric functional abdominal pain (”FAP”) associated with irritable bowel syndrome (”IBS”), a multi-billion dollar market. Since we introduced NeurAxis about a year ago, the IB-Stim has been included in the pediatric guideline…